Bolt Biotherapeutics Inc.

NASDAQ: BOLT · Real-Time Price · USD
0.29
-0.03 (-10.44%)
At close: Jun 05, 2025, 3:59 PM
0.30
1.66%
Pre-market: Jun 06, 2025, 08:23 AM EDT

Bolt Biotherapeutics Statistics

Share Statistics

Bolt Biotherapeutics has 38.34M shares outstanding. The number of shares has increased by 0.56% in one year.

38.34M
0.56%
0.17%
48.81%
n/a
638
0.19%

Short Selling Information

The latest short interest is 256.53K, so 0.67% of the outstanding shares have been sold short.

256.53K
0.67%
0.67%
2.07

Valuation Ratios

The PE ratio is -0.32 and the forward PE ratio is -0.33. Bolt Biotherapeutics's PEG ratio is 0.03.

-0.32
-0.33
2.66
0.7
0.36
-0.33
0.03
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Bolt Biotherapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 3.2, with a Debt / Equity ratio of 0.44.

3.2
3.2
0.44
-0.38
-0.41
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$147,884.62
$-1,213,807.69
52
0.08
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -61.33% in the last 52 weeks. The beta is 0.91, so Bolt Biotherapeutics's price volatility has been higher than the market average.

0.91
-61.33%
0.35
0.51
40.53
331,980

Income Statement

In the last 12 months, Bolt Biotherapeutics had revenue of 7.69M and earned -63.12M in profits. Earnings per share was -1.65.

7.69M
5.51M
-73.05M
-63.12M
-66.45M
-68.24M
-1.65
Full Income Statement

Balance Sheet

The company has 7.21M in cash and 25.21M in debt, giving a net cash position of -18M.

7.21M
25.21M
-18M
-427.4M
85.86M
28.95M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -61.29M and capital expenditures -41K, giving a free cash flow of -61.33M.

-61.29M
-41K
-61.33M
-1.61
Full Cash Flow Statement

Margins

Gross margin is 71.64%, with operating and profit margins of -949.91% and -820.78%.

71.64%
-949.91%
-820.78%
-820.78%
-864.17%
-949.91%
-797.53%

Dividends & Yields

BOLT does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for BOLT is $2.5, which is 762.1% higher than the current price. The consensus rating is "Hold".

$2.5
762.1%
Hold
3
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-8.97
2